Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2022-04-28 00:00:00 ET · period of report 2022-04-26 · accession 0001171843-22-002980 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-28 | 2022-04-26 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +24.6K | 72.8K | +51% | $0 |
| D | 2022-04-28 | 2022-04-26 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | -24.6K | 24.6K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-26 | M | A | 24,576 | $0.00 | 72,826 | D | — | — | (F1) Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on April 26, 2020. The 24,576 shares resulting from the RSU vest were retained in full as a result of Dr. Blanchard's election to pay cash to cover the applicable taxes resulting from the RSU vest. |
| 2 | Derivative | Restricted Stock Unit | 2022-04-26 | M | D | 24,576 | $0.00 | 24,575 | D | $0.00 · — to — | 24,576 Common Stock | (F3) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning April 26, 2021. |